or Try an Advanced Search...

    Recent News for FBIOP - Fortress Biotech, Inc. - 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

    Date Title
    Jul 2 Checkpoint Therapeutics Announces $12 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Jul 2 Checkpoint Therapeutics Announces Biologics License Application Resubmission for Cosibelimab
    Jun 24 Checkpoint Therapeutics Announces Alignment with FDA Enabling Upcoming Cosibelimab BLA Resubmission
    Jun 21 Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Jun 20 Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
    Jun 20 Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
    Back to the Main FBIOP Page...